Provectus Biopharmaceuticals, Inc. announced that it has appointed Brendan O'Brien to its strategic advisory board. Brendan O'Brien is currently VP of Strategic Planning & Analysis for North American Pharmaceuticals at Sanofi. In this role, he is responsible for business planning and strategy development; he leads both the three-year strategic planning and one-year operating planning processes for Sanofi US, the North American affiliate of Sanofi SA.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1797 USD | -5.42% | -3.39% | +87.19% |
1st Jan change | Capi. | |
---|---|---|
+87.19% | 79.71M | |
+8.86% | 115B | |
+9.65% | 105B | |
-12.90% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.92% | 16.52B | |
-16.28% | 16.01B | |
+1.54% | 14.14B | |
+17.75% | 10.71B |
- Stock Market
- Equities
- PVCT Stock
- News Provectus Biopharmaceuticals, Inc.
- Provectus Biopharmaceuticals Inc. Appoints Brendan O'Brien to Strategic Advisory Board